OmniAb, Inc. (NASDAQ:OABI) CFO Kurt A. Gustafson Sells 7,255 Shares

OmniAb, Inc. (NASDAQ:OABI - Get Free Report) CFO Kurt A. Gustafson sold 7,255 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $3.67, for a total transaction of $26,625.85. Following the completion of the sale, the chief financial officer now owns 206,211 shares of the company's stock, valued at approximately $756,794.37. The trade was a 3.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

OmniAb Price Performance

OABI traded down $0.23 during trading on Friday, hitting $3.65. 635,557 shares of the stock traded hands, compared to its average volume of 508,669. The firm has a 50-day moving average of $3.49 and a 200 day moving average of $3.91. OmniAb, Inc. has a 12-month low of $3.10 and a 12-month high of $6.55. The firm has a market capitalization of $515.45 million, a P/E ratio of -5.89 and a beta of -0.12.

Analysts Set New Price Targets

OABI has been the subject of several analyst reports. HC Wainwright restated a "buy" rating and set a $11.00 price target on shares of OmniAb in a research report on Thursday, November 14th. Benchmark restated a "buy" rating and set a $8.00 target price on shares of OmniAb in a report on Thursday, November 14th.

Institutional Trading of OmniAb

A number of institutional investors have recently modified their holdings of OABI. Janus Henderson Group PLC increased its holdings in OmniAb by 1.1% during the 4th quarter. Janus Henderson Group PLC now owns 7,960,321 shares of the company's stock valued at $28,179,000 after purchasing an additional 88,993 shares during the period. Dimensional Fund Advisors LP grew its position in shares of OmniAb by 4.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,025,674 shares of the company's stock worth $10,711,000 after buying an additional 142,513 shares during the last quarter. Rice Hall James & Associates LLC increased its stake in shares of OmniAb by 6.4% during the third quarter. Rice Hall James & Associates LLC now owns 2,722,321 shares of the company's stock valued at $11,515,000 after buying an additional 163,038 shares during the period. Geode Capital Management LLC raised its holdings in shares of OmniAb by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 2,353,442 shares of the company's stock valued at $8,333,000 after acquiring an additional 28,061 shares in the last quarter. Finally, State Street Corp lifted its stake in OmniAb by 1.7% in the third quarter. State Street Corp now owns 2,031,676 shares of the company's stock worth $8,594,000 after acquiring an additional 34,654 shares during the period. 72.08% of the stock is currently owned by hedge funds and other institutional investors.

About OmniAb

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.